Pharmacological treatment of ADHD [Attention-deficit hyperactivity disorder] in young children

Trial Profile

Pharmacological treatment of ADHD [Attention-deficit hyperactivity disorder] in young children

Completed
Phase of Trial: Phase IV

Latest Information Update: 09 Dec 2015

At a glance

  • Drugs Atomoxetine (Primary)
  • Indications Attention-deficit hyperactivity disorder
  • Focus Therapeutic Use
  • Most Recent Events

    • 21 Mar 2011 Primary endpoint 'Attention Deficit Hyperactivity Disorder Rating Scale' has been met according to results published in Pediatrics.
    • 21 Mar 2011 Status changed from recruiting to completed as published in Pediatrics.
    • 21 Mar 2011 Results published in Pediatrics.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top